Close menu




 

Carsten Mainitz

  • Small-Caps
  • Micro-Caps
  • Behavioral Finance

The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

Most recently, he headed a Hamburg-based investment research company as a member of the board for 8 years.

He is particularly interested in international small and micro caps and empirical capital market research (behavioral finance).


Commented by Carsten Mainitz

Commented by Carsten Mainitz on October 7th, 2025 | 07:45 CEST

Aspermont, Palantir, RENK – AI sets the pace. Where is the next run?

  • Digitization
  • Technology
  • AI
  • Defense
  • Software
  • bigdata

International stock markets are booming. The Dow Jones recently surpassed 47,000 points, seemingly unaffected by the US government shutdown. The topic of artificial intelligence (AI) continues to be the focus of investor interest, and recent company announcements are causing a stir. Japanese electronics giant Hitachi and ChatGPT provider OpenAI are partnering to build AI infrastructure and global data centers. Meanwhile, Fujitsu and leading AI chip manufacturer Nvidia are expanding their collaboration and plan to jointly develop a platform that uses AI in a targeted manner for specific industries, such as healthcare and robotics. In view of the AI boom, it is becoming increasingly compelling to explore second- and third-tier stocks that could benefit from the surge in innovation and investor interest.

Read

Commented by Carsten Mainitz on October 2nd, 2025 | 07:10 CEST

NetraMark Holdings, Evotec, Sartorius – Billion-dollar deals in sight!

  • Biotechnology
  • Biotech
  • AI
  • Pharma

Artificial intelligence and machine learning have become key drivers across nearly every industry. When pharmaceutical companies successfully develop a drug to market readiness, profits can surge. However, only a few active ingredients that enter clinical trials ultimately receive approval. It is therefore a long, risky, and costly process. The use of AI can help to minimize these risks significantly. Here, we take a look at the potential of AI-based strategies among established players Evotec and Sartorius, with a particular focus on the innovative approach of Canadian company NetraMark Holdings.

Read

Commented by Carsten Mainitz on October 1st, 2025 | 07:05 CEST

Almonty Industries, Gerresheimer, BASF – It is not too late yet!

  • Mining
  • Tungsten
  • Defense
  • chemicals
  • Pharma

The race for critical high-tech goods and raw materials is already underway. The COVID-19 pandemic painfully highlighted the downsides of a globally interconnected economy. China's export ban on critical raw materials is currently having a double impact, as the country dominates the market. This effect is expected to continue to intensify in the future as demand continues to rise dynamically while supply increases only slowly. This provides a strong tailwind for raw material producers, but poses significant challenges for companies in other sectors.

Read

Commented by Carsten Mainitz on September 30th, 2025 | 07:40 CEST

Antimony Resources, Rheinmetall, Novo Nordisk – Something is in the air!

  • Mining
  • antimony
  • Defense
  • Biotechnology

Sufficient access to raw materials is crucial for any economy. The EU has compiled a list of 34 critical raw materials. How critical a raw material is classified depends on two parameters: "economic importance" and "supply risk." This list also includes a little-known but very important metalloid – antimony. The price of antimony skyrocketed at the end of 2024 in the wake of China's export ban. There are still exciting investment opportunities in this area.

Read

Commented by Carsten Mainitz on September 26th, 2025 | 07:35 CEST

Gerresheimer, dynaCERT, Volkswagen – Exciting developments!

  • Hydrogen
  • greenhydrogen
  • cleantech
  • Electromobility
  • Healthcare
  • Pharma

News drives prices. However, the pendulum can swing in both directions. For informed investors, the correct interpretation of events is crucial. Often, this then leads to lucrative entry and exit signals. Gerresheimer was the latest to be hit, but which stock could be next? However, there are also stocks that are due for a realignment, offering opportunities for rising prices.

Read

Commented by Carsten Mainitz on September 22nd, 2025 | 07:55 CEST

AJN Resources, TUI, Evotec: Fresh capital and insider purchases!

  • Mining
  • Gold
  • Commodities
  • travel
  • Biotechnology

Fresh capital, insider purchases, or significant changes in the shareholder base can be important signals regarding future share price performance. The leverage effect of fresh capital is particularly high for smaller companies. This is because projects can be launched with manageable amounts of capital, bringing important milestones closer. However, the stock market sometimes reacts late because small or micro-caps fly under the radar of the investor community. However, it is precisely this constellation that creates good opportunities for active and vigilant investors.

Read

Commented by Carsten Mainitz on September 18th, 2025 | 07:00 CEST

Almonty Industries, thyssenkrupp, Nordex – Perfect news!

  • Mining
  • Tungsten
  • Steel
  • renewableenergies

Rare earths and critical raw materials play a vital role across many sectors of the economy. They are essential for electric motors, permanent magnets, and battery technologies and are of great importance in the defense industry. China controls the majority of global reserves and is restricting exports. Western countries have long been making great efforts to secure deposits outside China, with particular pressure coming from the US. A recently published report by Bloomberg has raised eyebrows.

Read

Commented by Carsten Mainitz on September 17th, 2025 | 07:20 CEST

Globex Mining, Deutz, Novo Nordisk – Prices are rising!

  • Mining
  • Gold
  • Commodities
  • Defense
  • Biotechnology

On the stock market, there is often a difference between price and value. Companies with strong assets and holdings, or those with business models that benefit from long-term trends, tend to deliver attractive returns for investors in the long run. All the better if such companies can be acquired at a favorable price - one that lies below the fair value of their shares.

Read

Commented by Carsten Mainitz on September 17th, 2025 | 07:05 CEST

Pure Hydrogen, Rheinmetall, RENK – Tailwind from the Fed and positive news

  • Hydrogen
  • cleantech
  • greenhydrogen
  • Defense

This week, decisions from several central banks are on the agenda. The US Federal Reserve is considered the most important signal setter. Investors firmly expect the Fed to cut interest rates by 25 basis points. In addition, stock market participants are eagerly awaiting signals from Fed Chair Jerome Powell regarding the further pace of monetary easing. Stocks from the commodities and defense sectors remain at the top of the list of favorites.

Read

Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

Verbio, Kleos Space, KWS Saat - This news is moving share prices!

  • Space
  • Technology
  • Investments

Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.

Read